BlackRock Group’s Clovis Oncology, Inc. CLVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$930K Sell
20,918
-5,342
-20% -$238K ﹤0.01% 2150
2016
Q3
$947K Buy
26,260
+8,335
+46% +$301K ﹤0.01% 2048
2016
Q2
$246K Sell
17,925
-2,825
-14% -$38.8K ﹤0.01% 2495
2016
Q1
$398K Buy
20,750
+3,895
+23% +$74.7K ﹤0.01% 2312
2015
Q4
$589K Buy
16,855
+789
+5% +$27.6K ﹤0.01% 2119
2015
Q3
$1.48M Buy
16,066
+4,887
+44% +$449K ﹤0.01% 1651
2015
Q2
$982K Buy
11,179
+5,307
+90% +$466K ﹤0.01% 1962
2015
Q1
$435K Buy
5,872
+1,063
+22% +$78.7K ﹤0.01% 2239
2014
Q4
$269K Buy
4,809
+385
+9% +$21.5K ﹤0.01% 2423
2014
Q3
$201K Sell
4,424
-110
-2% -$5K ﹤0.01% 2435
2014
Q2
$188K Sell
4,534
-4,874
-52% -$202K ﹤0.01% 2448
2014
Q1
$652K Buy
9,408
+2,216
+31% +$154K ﹤0.01% 2127
2013
Q4
$433K Sell
7,192
-23,798
-77% -$1.43M ﹤0.01% 2235
2013
Q3
$1.88M Sell
30,990
-29,589
-49% -$1.8M ﹤0.01% 1491
2013
Q2
$4.06M Buy
+60,579
New +$4.06M ﹤0.01% 1028